logoTry Persana

Nomic Bio - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Nomic Bio including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Nomic Bio company logo

The Protein Profiling Company.

Nomic Bio was founded to make biology easier to measure and enables scientists to extend lives by making proteomics accessible, scalable, and routine.

HeadquartersMontreal, Canada
Team size51-100
Founded2017

What is Nomic Bio? - Company Overview & Details

Nomic Bio is Nomic Bio was founded to make biology easier to measure and enables scientists to extend lives by making proteomics accessible, scalable, and routine. Founded in 2017, the company is headquartered in Montreal, Canada.

Who Founded Nomic Bio?

Nomic Bio was founded by Milad Dagher.

Who are the Key Executives at Nomic Bio? - Leadership Team

Nomic Bio is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Nomic Bio

Milad DagherCEO

Chief Technology Officer (CTO) of Nomic Bio

Jeff MunzarCTO

About Milad Dagher - CEO of Nomic Bio

Milad Dagher serves as the Chief Executive Officer of Nomic Bio, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Nomic Bio Company Details & Key Information

Where is Nomic Bio located?

Nomic Bio is headquartered in Montreal, Canada.

How many employees does Nomic Bio have?

Nomic Bio has 51-100 employees.

When was Nomic Bio founded?

Nomic Bio was founded in 2017.

Nomic Bio Official Website

How much funding has Nomic Bio raised?

Nomic Bio has raised $56 Million across 2 funding rounds. The most recent funding was completed on 2024-10-17.

Funding Overview

Nomic Bio has raised funds via Series A and Series B rounds, amounting to a total of $56 million for enhancing its protein profiling platform.

$56 Million
Total Funding Raised
2
Funding Rounds
2024-10-17
Latest Round

Nomic Bio Funding History

Series A
2022-01-08
$17 Million
Series B
2024-10-17
$42 Million

Who are the key investors in Nomic Bio?

Nomic Bio is backed by 1 key investors including Lux Capital. These investors focus on Biotechnology, Deep Tech, Healthcare sectors.

Nomic Bio Investor Overview

1
Key Investors
3
Focus Areas
1
Notable Investments

Complete List of Nomic Bio Investors

Lux Capital

A venture capital firm investing in emerging tech companies.

Investment Focus
Biotechnology
Deep Tech
Healthcare
Notable Portfolio Companies
Nomic Bio

What sectors do Nomic Bio investors focus on?

The investors backing Nomic Bio primarily focus on Biotechnology, Deep Tech, Healthcare sectors.

Biotechnology
Deep Tech
Healthcare

Featured Investor: Lux Capital

Lux Capital

A venture capital firm investing in emerging tech companies.

Notable Investments: Nomic Bio

What are Nomic Bio's future plans?

Nomic Bio Nomic Bio aims to continue expanding its proteomics offerings and increase accessibility across research domains.

Nomic Bio Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Nomic Bio face?

Nomic Bio has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Nomic Bio

1

Meeting the growing demand for protein data

2

Expanding the target library for Nomic Flex

What opportunities does Nomic Bio have?

Nomic Bio has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Nomic Bio

1

Scaling proteomics with unmatched precision

2

Enhancing applications in drug discovery and biomarker validation

Nomic Bio Strategic Position Summary

Key Focus Areas

Nomic Bio is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Nomic Bio?

Nomic Bio has 2 recent news updates covering key business developments and market activities.

Nomic Bio News Overview

2
Recent Articles
Active
Media Coverage
2024-09-17
Latest Update

What is Nomic Bio in the news for?

Nomic Bio is currently featured in news for Nomic Bio receives financing of $42M in Series B. and other significant business developments.

Recent News Articles About Nomic Bio

Article 1
2024-09-17

Nomic Bio receives financing of $42M in Series B.

Nomic Bio secures $42 million in Series B funding to expand its proteomics platform.

venturecapital.com
Read News
Article 2
2023-06-30

Nomic Bio hired Byron Hewett as board of directors on Jun 28th '23.

Nomic Bio announces the appointment of Byron Hewett to its board to guide the company through crucial growth years.

raptorgroup.com
Read News

Nomic Bio FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Nomic Bio including information about founders, CEO, funding history, investors, headquarters location, and company details. 19 frequently asked questions covering key information about the company.

Nomic Bio Questions & Answers - Company Information

Q1

What is Nomic Bio?

Nomic Bio was founded to make biology easier to measure and enables scientists to extend lives by making proteomics accessible, scalable, and routine.

Q2

Who founded Nomic Bio?

Nomic Bio was founded by Milad Dagher.

Q3

Who is the CEO of Nomic Bio?

The CEO of Nomic Bio is Milad Dagher. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Nomic Bio raised?

Nomic Bio has raised a total of $$56 Million across 2 funding rounds. The most recent funding was completed on 2024-10-17.

Q5

Who are the investors in Nomic Bio?

Nomic Bio's key investors include Lux Capital.

Q6

Where is Nomic Bio headquartered?

Nomic Bio is headquartered in Montreal, Canada.

Q7

When was Nomic Bio founded?

Nomic Bio was founded in 2017.

Q8

How many employees does Nomic Bio have?

Nomic Bio has 51-100 employees.

Q9

What is Nomic Bio's official website?

You can visit Nomic Bio's official website at http://www.nomic.bio.

Q10

What was Nomic Bio's latest funding round?

Nomic Bio's latest funding round was a Series A round of $$17 Million completed on 2022-01-08.

Q11

Who is founder?

Milad Dagher

Q12

Who is cto?

Jeff Munzar

Q13

What does the company do?

Nomic Bio focuses on making biology easier to measure through accessible and scalable proteomics solutions.

Q14

How much funding?

$56 Million

Q15

Latest funding date?

2024-10-17

Q16

Who are the investors?

Lux Capital

Q17

What are the challenges?

Meeting the growing demand for protein data Expanding the target library for Nomic Flex

Q18

What are the opportunities?

Scaling proteomics with unmatched precision Enhancing applications in drug discovery and biomarker validation

Q19

Latest news?

Nomic Bio secures $42 million in Series B funding to expand its proteomics platform. Nomic Bio announces the appointment of Byron Hewett to its board to guide the company through crucial growth years.

More Information About Nomic Bio

For additional details about Nomic Bio, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.